Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myelomaMarek Hus, Anna Dmoszyńska, Wojciech Legieć et al.|Annals of Hematology|2011Cited by 62
Imatinib mesylate may induce long-term clinical response in FIP1L1-PDGFRα-negative hypereosinophilic syndromeGrzegorz Helbig, Sławomira Kyrcz‐Krzemień, Marek Hus et al.|Medical Oncology|2011Cited by 28
Durable remission after treatment with very low doses of imatinib for FIP1L1-PDGFRα-positive chronic eosinophilic leukaemiaGrzegorz Helbig, Sławomira Kyrcz‐Krzemień, Andrzej Moskwa et al.|Cancer Chemotherapy and Pharmacology|2011Cited by 24
Clinical characteristics of patients with chronic eosinophilic leukaemia (CEL) harbouring FIP1L1‐PDGFRA fusion transcript—results of Polish multicentre studyGrzegorz Helbig, Sławomira Kyrcz‐Krzemień, Andrzej Moskwa et al.|Hematological Oncology|2009Cited by 23